FI891020L - Menetelmä proteaasi-inhibiittoriaktiivisuutta omaavien egliinimutanttien valmistamiseksi - Google Patents
Menetelmä proteaasi-inhibiittoriaktiivisuutta omaavien egliinimutanttien valmistamiseksi Download PDFInfo
- Publication number
- FI891020L FI891020L FI891020A FI891020A FI891020L FI 891020 L FI891020 L FI 891020L FI 891020 A FI891020 A FI 891020A FI 891020 A FI891020 A FI 891020A FI 891020 L FI891020 L FI 891020L
- Authority
- FI
- Finland
- Prior art keywords
- preparing
- protease inhibitor
- inhibitor activity
- eglin mutants
- eglin
- Prior art date
Links
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 title 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
- C12N15/8286—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for insect resistance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/10—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
- Y02A40/146—Genetically Modified [GMO] plants, e.g. transgenic plants
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/855—Proteins from animals other than mammals or birds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Plant Pathology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Pest Control & Pesticides (AREA)
- Insects & Arthropods (AREA)
- Tropical Medicine & Parasitology (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Immunology (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH84088 | 1988-03-07 | ||
CH84088 | 1988-03-07 |
Publications (4)
Publication Number | Publication Date |
---|---|
FI891020A0 FI891020A0 (fi) | 1989-03-03 |
FI891020L true FI891020L (fi) | 1989-09-08 |
FI96116B FI96116B (fi) | 1996-01-31 |
FI96116C FI96116C (fi) | 1996-05-10 |
Family
ID=4196431
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI891020A FI96116C (fi) | 1988-03-07 | 1989-03-03 | Menetelmä proteaasi-inhibiittoriaktiivisuutta omaavien egliinimutanttien valmistamiseksi |
Country Status (20)
Country | Link |
---|---|
US (1) | US5079229A (fi) |
EP (1) | EP0332576B1 (fi) |
JP (1) | JP2716191B2 (fi) |
KR (1) | KR0134377B1 (fi) |
AT (1) | ATE103930T1 (fi) |
AU (1) | AU623881B2 (fi) |
CA (1) | CA1339105C (fi) |
DD (1) | DD283645A5 (fi) |
DE (1) | DE58907373D1 (fi) |
DK (1) | DK107389A (fi) |
ES (1) | ES2063161T3 (fi) |
FI (1) | FI96116C (fi) |
HU (1) | HU209401B (fi) |
IE (1) | IE62993B1 (fi) |
IL (1) | IL89496A0 (fi) |
NO (1) | NO178870C (fi) |
NZ (1) | NZ228208A (fi) |
PT (1) | PT89916B (fi) |
TW (1) | TW211522B (fi) |
ZA (1) | ZA891679B (fi) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6342373B1 (en) * | 1983-11-21 | 2002-01-29 | Ucp Gen-Pharma Ag | Process for preparing recombinant eglin, protease inhibitor |
US5674833A (en) * | 1990-09-18 | 1997-10-07 | Novo Nordisk A/S | Detergent compositions containing protease and novel inhibitors for use therein |
US5604201A (en) * | 1993-01-08 | 1997-02-18 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University, A Non-Profit Organization | Methods and reagents for inhibiting furin endoprotease |
TW492975B (en) * | 1993-07-26 | 2002-07-01 | Novartis Ag | Tryptase inhibitor |
US6579698B1 (en) | 1996-09-24 | 2003-06-17 | The Procter & Gamble Company | Stabilized proteinaceous protease inhibitors and variants thereof |
US7001884B2 (en) * | 2001-06-18 | 2006-02-21 | Regents Of The University Of Michigan | Eglin c based drugs for treatment of disease |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2125047B (en) * | 1982-08-09 | 1986-02-19 | Ciba Geigy Ag | Yeast hybrid vectors and their use for the production of polypeptides |
DE3324534A1 (de) * | 1983-07-07 | 1985-01-17 | Ciba-Geigy Ag, Basel | Modifizierte protease-inhibitoren, verfahren zu ihrer herstellung und daraus bereitete pharmazeutische mittel |
GR80965B (en) * | 1983-11-21 | 1985-03-20 | Ciba Geigy Ag | Method for the preparation of protease inhibitors |
US4711848A (en) * | 1984-03-14 | 1987-12-08 | Zymogenetics, Inc. | Site specific mutagenesis in alpha-1-antitrypsin |
DE3585969D1 (de) * | 1984-06-14 | 1992-06-11 | Chiron Corp | Protease-inhibitoren des alpha-1-antitrypsin typs mit modifizierter aktiever stelle und deren herstellung. |
HU204563B (en) * | 1984-12-06 | 1992-01-28 | Synergen Biolog Inc | Process for producing recombinant serine-protease inhibitors and dns sequencyes for them |
GB2188322A (en) * | 1986-03-26 | 1987-09-30 | Bayer Ag | Aprotinin and analogues thereof produced by a recombinant host |
GB2199582A (en) * | 1987-01-07 | 1988-07-13 | Bayer Ag | Analogues of pancreatic secretory trypsin inhibitor |
-
1989
- 1989-02-28 ES ES89810152T patent/ES2063161T3/es not_active Expired - Lifetime
- 1989-02-28 DE DE89810152T patent/DE58907373D1/de not_active Expired - Fee Related
- 1989-02-28 AT AT89810152T patent/ATE103930T1/de not_active IP Right Cessation
- 1989-02-28 EP EP89810152A patent/EP0332576B1/de not_active Expired - Lifetime
- 1989-03-03 AU AU30959/89A patent/AU623881B2/en not_active Ceased
- 1989-03-03 FI FI891020A patent/FI96116C/fi not_active IP Right Cessation
- 1989-03-03 CA CA000592686A patent/CA1339105C/en not_active Expired - Fee Related
- 1989-03-03 NZ NZ228208A patent/NZ228208A/xx unknown
- 1989-03-06 IE IE71989A patent/IE62993B1/en not_active IP Right Cessation
- 1989-03-06 ZA ZA891679A patent/ZA891679B/xx unknown
- 1989-03-06 HU HU891101A patent/HU209401B/hu not_active IP Right Cessation
- 1989-03-06 PT PT89916A patent/PT89916B/pt not_active IP Right Cessation
- 1989-03-06 DD DD89326310A patent/DD283645A5/de not_active IP Right Cessation
- 1989-03-06 DK DK107389A patent/DK107389A/da not_active Application Discontinuation
- 1989-03-06 IL IL89496A patent/IL89496A0/xx not_active IP Right Cessation
- 1989-03-06 NO NO890932A patent/NO178870C/no not_active IP Right Cessation
- 1989-03-07 US US07/320,139 patent/US5079229A/en not_active Expired - Fee Related
- 1989-03-07 TW TW078101663A patent/TW211522B/zh active
- 1989-03-07 KR KR1019890002759A patent/KR0134377B1/ko not_active Expired - Fee Related
- 1989-03-07 JP JP1053065A patent/JP2716191B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0332576A3 (en) | 1990-09-12 |
JP2716191B2 (ja) | 1998-02-18 |
US5079229A (en) | 1992-01-07 |
DD283645A5 (de) | 1990-10-17 |
IE62993B1 (en) | 1995-03-08 |
HU209401B (en) | 1994-05-30 |
EP0332576B1 (de) | 1994-04-06 |
FI96116B (fi) | 1996-01-31 |
KR890014735A (ko) | 1989-10-25 |
CA1339105C (en) | 1997-07-29 |
DK107389D0 (da) | 1989-03-06 |
AU623881B2 (en) | 1992-05-28 |
NO178870C (no) | 1996-06-19 |
PT89916A (pt) | 1989-11-10 |
DE58907373D1 (de) | 1994-05-11 |
ES2063161T3 (es) | 1995-01-01 |
ATE103930T1 (de) | 1994-04-15 |
KR0134377B1 (ko) | 1998-04-20 |
EP0332576A2 (de) | 1989-09-13 |
FI891020A0 (fi) | 1989-03-03 |
DK107389A (da) | 1989-09-08 |
AU3095989A (en) | 1989-09-07 |
NO890932D0 (no) | 1989-03-06 |
IL89496A0 (en) | 1989-09-10 |
NO890932L (no) | 1989-09-08 |
NO178870B (no) | 1996-03-11 |
FI96116C (fi) | 1996-05-10 |
JPH029392A (ja) | 1990-01-12 |
TW211522B (fi) | 1993-08-21 |
IE890719L (en) | 1989-09-07 |
HUT50503A (en) | 1990-02-28 |
PT89916B (pt) | 1994-05-31 |
ZA891679B (en) | 1989-10-25 |
NZ228208A (en) | 1990-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI882007A0 (fi) | Menetelmä steroidi-5- -reduktaasin inhibiittorien valmistamiseksi | |
FI893158L (fi) | Menetelmä tetrahydrofolaattien valmistamiseksi | |
FI891711L (fi) | Menetelmä diorganodialkoksisilaanien valmistamiseksi | |
BR8907457A (pt) | Inibidores de interleucina-1 | |
FI883052L (fi) | Menetelmä puun suojaamiseksi | |
FI890123A0 (fi) | Menetelmä valmistaa terapeuttisesti vaikuttavia indolyylipiperidiiniyhdisteitä | |
KR890016060A (ko) | N2--l-리신 유도체 및 이를 사용한 리시노프릴의 제조방법 | |
KR900009566A (ko) | 말레이미드류의 제조법 | |
DK639589D0 (da) | Forbraendingsproces | |
DK444889A (da) | Hoejtryks-natriumdampudladningslampe | |
DK46388D0 (da) | Indretning til boretaarn | |
FI891020L (fi) | Menetelmä proteaasi-inhibiittoriaktiivisuutta omaavien egliinimutanttien valmistamiseksi | |
MX164735B (es) | Un metodo para la determinacion de bilirrubina en solucion | |
KR900702433A (ko) | 레퍼런스점 복귀방식 | |
IT9020623A0 (it) | procedimento | |
KR890013292A (ko) | 녹화기반 조성 공법 | |
FI891866L (fi) | Menetelmä terapeuttisesti käyttökelpoisten sulfonanilidien valmistamiseksi | |
BR8805933A (pt) | Metodo para testar enzimas | |
FI891256L (fi) | Aryylisulfonyylialkyyliamidien synteesimenetelmä | |
DK69489A (da) | Aspartattranscarbamylase-inhibitorer | |
KR900002722U (ko) | 연탄제조용 윤전기의 압축대 | |
ATA204288A (de) | Betteinsatz | |
NO903496L (no) | Fremgangsmaate for metanomdanning. | |
DE3877180D1 (de) | Dickenmessverfahren. | |
IT8967056A0 (it) | Procedimento di immunizzazione ma gnetica in particolare per mezzi navali |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BB | Publication of examined application | ||
PC | Transfer of assignment of patent |
Owner name: NOVARTIS AG |
|
MM | Patent lapsed |
Owner name: NOVARTIS AG Owner name: UCP GEN-PHARMA AG |